Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression? - PubMed (original) (raw)
Clinical Trial
Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression?
Ward T Smith et al. J Affect Disord. 2002 Aug.
Abstract
Background: Clonazepam cotherapy of fluoxetine was previously demonstrated to accelerate efficacy over the first 3 weeks of treatment. A new 18-week double-blind study attempted to replicate these findings to determine whether superiority would extend to 3 months and assess risks of extension.
Method: Fifty outpatient volunteers aged 18-65 from Seattle and Portland with moderate-marked depression received fluoxetine (20 mg) doubled at 6 weeks if needed; half took clonazepam (0.5 mg) and half took an identical placebo, 1 or 2 tablets adjusted during the first 2 weeks, until a 3-week taper at 3 months.
Results: No serious adverse events and no special problems with sedation or discontinuation were noted. Cotherapy was superior to fluoxetine monotherapy at Day 7 for HAM-D (t=2.03, df=48, P<0.05) and CGI-I (32 vs. 4% responders, P<0.03, Fisher Exact Test) but not otherwise. Cotherapy was effective in reducing insomnia but not anxiety or core symptoms (low mood, suicidality, reduced interest). The only significant benefit of extending treatment was a more rapid response to increased fluoxetine at 6 weeks manifested in a mean HAM-D of 9.0 and CGI-I responder rate of 76% after 8 weeks compared to 16 weeks for monotherapy.
Limitations: Small sample size (N=50) limited power and rendered conclusions tentative.
Conclusions: Extended clonazepam cotherapy of fluoxetine appeared safe and effective for depressed outpatients: it was superior to fluoxetine alone early in treatment and again following fluoxetine dose increase. Cotherapy might be considered at the start of fluoxetine treatment, especially for those with insomnia, and when a dose increase of fluoxetine is anticipated.
Copright 2002 Elsevier Science BV.
Similar articles
- Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression.
Londborg PD, Smith WT, Glaudin V, Painter JR. Londborg PD, et al. J Affect Disord. 2000 Dec;61(1-2):73-9. doi: 10.1016/s0165-0327(99)00195-0. J Affect Disord. 2000. PMID: 11099743 Clinical Trial. - Fluoxetine-clonazepam cotherapy for anxious depression: an exploratory, post-hoc analysis of a randomized, double blind study.
Papakostas GI, Clain A, Ameral VE, Baer L, Brintz C, Smith WT, Londborg PD, Glaudin V, Painter JR, Fava M. Papakostas GI, et al. Int Clin Psychopharmacol. 2010 Jan;25(1):17-21. doi: 10.1097/YIC.0b013e32833205a4. Int Clin Psychopharmacol. 2010. PMID: 19898245 Clinical Trial. - Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group.
Silverstone PH, Ravindran A. Silverstone PH, et al. J Clin Psychiatry. 1999 Jan;60(1):22-8. doi: 10.4088/jcp.v60n0105. J Clin Psychiatry. 1999. PMID: 10074873 Clinical Trial. - A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression.
Rudolph RL, Feiger AD. Rudolph RL, et al. J Affect Disord. 1999 Dec;56(2-3):171-81. doi: 10.1016/s0165-0327(99)00067-1. J Affect Disord. 1999. PMID: 10701474 Clinical Trial. - Once-weekly fluoxetine.
Wagstaff AJ, Goa KL. Wagstaff AJ, et al. Drugs. 2001;61(15):2221-8; discussion 2229-30. doi: 10.2165/00003495-200161150-00006. Drugs. 2001. PMID: 11772132 Review.
Cited by
- Depression in adults: drug and physical treatments.
Cipriani A, Barbui C, Butler R, Hatcher S, Geddes J. Cipriani A, et al. BMJ Clin Evid. 2011 May 25;2011:1003. BMJ Clin Evid. 2011. PMID: 21609510 Free PMC article. Review. - Pharmacotherapy Treatment Options for Insomnia: A Primer for Clinicians.
Asnis GM, Thomas M, Henderson MA. Asnis GM, et al. Int J Mol Sci. 2015 Dec 30;17(1):50. doi: 10.3390/ijms17010050. Int J Mol Sci. 2015. PMID: 26729104 Free PMC article. Review. - Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms.
Mancino MJ, McGaugh J, Chopra MP, Guise JB, Cargile C, Williams DK, Thostenson J, Kosten TR, Sanders N, Oliveto A. Mancino MJ, et al. J Clin Psychopharmacol. 2014 Apr;34(2):234-9. doi: 10.1097/JCP.0000000000000062. J Clin Psychopharmacol. 2014. PMID: 24525654 Free PMC article. Clinical Trial. - Insomnia in patients with depression: some pathophysiological and treatment considerations.
Jindal RD. Jindal RD. CNS Drugs. 2009;23(4):309-29. doi: 10.2165/00023210-200923040-00004. CNS Drugs. 2009. PMID: 19374460 Review. - Depression in adults: drug and physical treatments.
Barbui C, Butler R, Cipriani A, Geddes J, Hatcher S. Barbui C, et al. BMJ Clin Evid. 2007 Jun 15;2007:1003. BMJ Clin Evid. 2007. PMID: 19454086 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous